Patient Safety and Quality Improvement Act
The Patient Safety and Quality Improvement Act of 2005 :, 42 U.S.C. , established a system of patient safety organizations and a national patient safety database. To encourage reporting and broad discussion of adverse events, near misses, and dangerous conditions, it also established privilege and confidentiality protections for Patient Safety Work Product. The PSQIA was introduced by Sen. Jim Jeffords . It passed in the Senate July 21, 2005 by unanimous consent, and passed the House of Representatives on July 27, 2005 with 428 Ayes, 3 Nays, and 2 Present/Not Voting.
Context for the passage of the Act
The Notice of proposed rulemaking for this law describes the reason Congress passed it.Summary of the act's major sections
Definitions
Patient Safety Organization must certify that it supports the requirements in the PSQIA and be on the Agency for Healthcare Research and Quality web site.The definition of Patient Safety Work Product is quite broad. Patient safety work product includes any data, reports, records, memoranda, analyses, or written or oral statements, which are assembled or developed by a provider for reporting to a PSO and are reported to a PSO; or are developed by a patient safety organization for the conduct of patient safety activities; and which could result in improved patient safety, health care quality, or health care outcomes; or which identify or constitute the deliberations or analysis or, or identify the fact of reporting pursuant to a patient safety evaluation system ).
However, patient safety work product does not include a patient's medical record, billing and discharge information, or any other original patient or provider records; nor does it include information that is collected, maintained, or developed separately, or exists separately, from a patient safety evaluation system.
Privilege and confidentiality protections
Patient Safety Work Product must not be disclosed, except in very specific circumstances and subject to very specific restrictions.Note: the Patient Safety Activities Exception is the most common one that providers and PSOs will be working with.
Permitted Disclosures
- Patient Safety Activities — PSWP may be disclosed:
- * Between the Provider and the PSO — i.e.:
- ** From the provider to the PSO, for Patient Safety Activities, and
- ** From the PSO to the disclosing provider, for Patient Safety Activities
- * To a contractor of a Provider or a PSO
- ** For contracted Patient Safety Activities
- ** Contractor may not further disclose, except back to the contracted provider or PSO
- * Among affiliated providers, for Patient Safety Activities
- ** From one PSO to another PSO or another provider, if
- *** Direct identifiers of any providers, affiliated organizations, corporate parents, subsidiaries, practice partners, employers, members of the workforce, or household members of such providers are removed; and
- *** With respect to any Individually identifiable health information within the PSWP, a limited data set is produced
- Business operations — A provider or PSO may disclose to attorneys, accountants or other professionals for business operations purposes.
- * Further disclosure is prohibited
- Authorized by identified providers — Disclosure is permitted if all identified providers authorize the disclosure.
- * Authorization must be in writing, signed by the provider, and
- * Must state the nature and scope of the disclosure
- Accrediting bodies — PSWP may be disclosed to an accrediting body if:
- * Any identified provider agrees to the disclosure; or
- * Direct identifiers of any provider are removed
- Nonidentifiable PSWP — May be disclosed
- * The regulations set out specific requirements for "nonidentification."
- Research — This exception allows disclosure to researchers conducting certain types of research projects. If protected health information is involved, the HIPAA privacy and security rules also apply.
- Food and Drug Administration — PSWP may be disclosed to the FDA
- * By a provider concerning an FDA-regulated product or activity,
- * By an entity required to report to the FDA about the quality, safety, or effectiveness of an FDA-regulated product or activity, or
- * By a contractor acting on behalf of the FDA or entity for these purposes
- Law enforcement — PSWP may be disclosed to law enforcement personnel
- * If the information relates to an event that either constitutes the commission of a crime, or for which the disclosing person reasonably believes constitutes the commission of a crime, provided that the disclosing person believes, reasonably under the circumstances, that the patient safety work product that is disclosed is necessary for criminal law enforcement purposes
- Criminal proceedings — But only after a court makes an in camera determination that:
- * The PSWP contains evidence of a criminal act;
- * The PSWP is material to the proceedings; and
- * The PSWP is not reasonably available from any other source
- Disclosure to permit equitable relief for reporting individuals — This exception allows use of PSWP by individuals who claim they have been the victim of an adverse employment action because the individual reported information to a PSO
- * There must be a "protective order" issued by the court or administrative tribunal to protect the confidentiality of PSWP used in the proceeding
- An individual who knowingly or recklessly violates the confidentiality provisions is subject to a civil penalty of up to $10,000 for each act constituting such violation.
- Safe Harbor — a provider whose workforce member discloses PSWP is not deemed to have violated the Act if that workforce member disclosure does not include written or oral statements that:
- * Assess the quality of care of an identifiable provider, or
- * Describe or pertain to one or more actions or failures to act by an identifiable provider
- PSWP may be disclosed to to investigate or determine compliance with the Patient Safety Act or with HIPAA.
Network of patient safety databases